Crescita Therap Drug Patent Portfolio
Crescita Therap owns 1 orange book drug protected by 5 US patents Given below is the list of Crescita Therap's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10350180 | Solid-forming local anesthetic formulations for pain control | 14 Jan, 2031 | Active |
| US10603293 | Solid-forming local anesthetic formulations for pain control | 14 Jan, 2031 | Active |
| US10751305 | Solid-forming topical formulations for pain control | 14 Jan, 2031 | Active |
| US6528086 | Methods and apparatus for drug delivery involving phase changing formulations | 28 Sep, 2019 | Expired |
| US5919479 | Noninvasive dermal anesthetics | 28 Jul, 2015 | Expired |
Latest Legal Activities on Crescita Therap's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Crescita Therap.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 26 Feb, 2024 | US10751305 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 02 Oct, 2023 | US10603293 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 16 Jan, 2023 | US10350180 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 25 Aug, 2020 | US10751305 |
|
Recordation of Patent Grant Mailed
Critical
| 25 Aug, 2020 | US10751305 |
|
Email Notification
Critical
| 07 Aug, 2020 | US10751305 |
|
Issue Notification Mailed
Critical
| 05 Aug, 2020 | US10751305 |
| Dispatch to FDC | 22 Jul, 2020 | US10751305 |
|
Application Is Considered Ready for Issue
Critical
| 20 Jul, 2020 | US10751305 |
|
Issue Fee Payment Received
Critical
| 15 Jul, 2020 | US10751305 |
|
Issue Fee Payment Verified
Critical
| 15 Jul, 2020 | US10751305 |
|
Electronic Review
Critical
| 30 Jun, 2020 | US10751305 |
|
Mail Notice of Allowance
Critical
| 29 Jun, 2020 | US10751305 |
|
Email Notification
Critical
| 29 Jun, 2020 | US10751305 |
|
Notice of Allowance Data Verification Completed
Critical
| 25 Jun, 2020 | US10751305 |
Crescita Therap's Family Patents
Crescita Therap Drug List
Given below is the complete list of Crescita Therap's drugs and the patents protecting them.
1. Pliaglis
Pliaglis is protected by 5 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10350180 | Solid-forming local anesthetic formulations for pain control |
14 Jan, 2031
(6 years from now)
| Active |
| US10603293 | Solid-forming local anesthetic formulations for pain control |
14 Jan, 2031
(6 years from now)
| Active |
| US10751305 | Solid-forming topical formulations for pain control |
14 Jan, 2031
(6 years from now)
| Active |
| US6528086 | Methods and apparatus for drug delivery involving phase changing formulations |
28 Sep, 2019
(5 years ago)
| Expired |
| US5919479 | Noninvasive dermal anesthetics |
28 Jul, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pliaglis's drug page